Renalytix plc (RNLX) - Year-over-year earnings per share growth for the last twelve months

Renalytix Plc (RNLX) is implementing AI systems for the preemptive detection of renal pathologies. Low geopolitical risks and access to developed markets guarantee business stability. High demand for diagnostics provides the company with pricing power. The history of quarterly EPS growth demonstrates real operational efficiency, where 0.00 shows the current volume of the metric on this chart.
renalytix.com (RNLX) - metric breakdowns and financial figures

The slow adoption of AI diagnostics and challenges with insurance coverage create a liquidity shortage risk for Renalytix Plc (RNLX). By analyzing quarter-over-quarter EPS dynamics, an investor can observe the mathematical change in net income per share, which allows them to filter out market noise and assess the real pressure of operating expenses on final margins and the business's market value.